$CTRN
Citi Trends Inc

2023 Q2 Form 10-Q Financial Statement

#000155837023010862 Filed on June 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue $179.7M
YoY Change -13.7%
Cost Of Revenue $113.7M
YoY Change -10.51%
Gross Profit $66.03M
YoY Change -18.69%
Gross Profit Margin 36.75%
Selling, General & Admin $70.81M
YoY Change -0.31%
% of Gross Profit 107.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.681M
YoY Change -14.03%
% of Gross Profit 7.09%
Operating Expenses $75.49M
YoY Change 6.28%
Operating Profit -$9.459M
YoY Change -123.85%
Interest Expense $948.0K
YoY Change 1147.37%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.511M
YoY Change -121.5%
Income Tax -$1.876M
% Of Pretax Income
Net Earnings -$6.635M
YoY Change -121.97%
Net Earnings / Revenue -3.69%
Basic Earnings Per Share -$0.81
Diluted Earnings Per Share -$0.81
COMMON SHARES
Basic Shares Outstanding 8.313M
Diluted Shares Outstanding 8.182M

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $88.71M
YoY Change 43.87%
Cash & Equivalents $88.71M
Short-Term Investments
Other Short-Term Assets $16.05M
YoY Change -1.83%
Inventory $114.3M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $219.1M
YoY Change 5.47%
LONG-TERM ASSETS
Property, Plant & Equipment $309.8M
YoY Change 354.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.529M
YoY Change 329.6%
Total Long-Term Assets $315.3M
YoY Change -0.05%
TOTAL ASSETS
Total Short-Term Assets $219.1M
Total Long-Term Assets $315.3M
Total Assets $534.4M
YoY Change 2.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.03M
YoY Change 2.47%
Accrued Expenses $71.25M
YoY Change 217.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $162.2M
YoY Change -7.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $212.3M
YoY Change 9750.3%
Total Long-Term Liabilities $212.3M
YoY Change 9750.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $162.2M
Total Long-Term Liabilities $212.3M
Total Liabilities $374.5M
YoY Change -1.98%
SHAREHOLDERS EQUITY
Retained Earnings $324.4M
YoY Change 7.29%
Common Stock $102.8M
YoY Change 1.39%
Preferred Stock
YoY Change
Treasury Stock (at cost) $267.2M
YoY Change 1.78%
Treasury Stock Shares
Shareholders Equity $160.0M
YoY Change
Total Liabilities & Shareholders Equity $534.4M
YoY Change 2.14%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income -$6.635M
YoY Change -121.97%
Depreciation, Depletion And Amortization $4.681M
YoY Change -14.03%
Cash From Operating Activities -$13.06M
YoY Change -30.85%
INVESTING ACTIVITIES
Capital Expenditures $950.0K
YoY Change -111.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$950.0K
YoY Change -102.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -783.0K
YoY Change -89.48%
NET CHANGE
Cash From Operating Activities -13.06M
Cash From Investing Activities -950.0K
Cash From Financing Activities -783.0K
Net Change In Cash -14.79M
YoY Change -224.59%
FREE CASH FLOW
Cash From Operating Activities -$13.06M
Capital Expenditures $950.0K
Free Cash Flow -$14.01M
YoY Change 28.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
31408
CY2023Q2 dei City Area Code
CityAreaCode
912
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2322000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8182000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8407000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8182000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8407000
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
39000
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
39000
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
393000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
346000
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001318484
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-03
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-29
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-51315
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
CITI TRENDS, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2150697
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
104 Coleman Boulevard
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Savannah
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
236-1561
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023Q2 dei Trading Symbol
TradingSymbol
CTRN
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8312902
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88707000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103495000
CY2023Q2 us-gaap Inventory Net
InventoryNet
114322000
CY2023Q1 us-gaap Inventory Net
InventoryNet
105794000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13851000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12977000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2203000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
615000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
219083000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
222881000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
265473000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
262525000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57383000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60106000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
252435000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
257195000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4395000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2893000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1134000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1183000
CY2023Q2 us-gaap Assets
Assets
534430000
CY2023Q1 us-gaap Assets
Assets
544258000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
90029000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
80670000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47780000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52661000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14987000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16055000
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
8486000
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
10823000
CY2023Q2 us-gaap Deferred Income
DeferredIncome
912000
CY2023Q1 us-gaap Deferred Income
DeferredIncome
344000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
162194000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
160553000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
209594000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
214939000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2680000
CY2023Q2 us-gaap Liabilities
Liabilities
374468000
CY2023Q1 us-gaap Liabilities
Liabilities
377814000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16116915
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16158494
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8312902
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8354481
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
160000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
160000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102598000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102445000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
324415000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
331050000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7804013
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7804013
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
267211000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
267211000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
159962000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
166444000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
534430000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
544258000
CY2023Q2 us-gaap Revenues
Revenues
179688000
CY2022Q2 us-gaap Revenues
Revenues
208215000
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
113659000
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
127011000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70807000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71026000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4681000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5445000
CY2022Q2 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
34920000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9459000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
39653000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1023000
CY2023Q2 us-gaap Interest Expense
InterestExpense
75000
CY2022Q2 us-gaap Interest Expense
InterestExpense
76000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8511000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39577000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1876000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9374000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6635000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
30203000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.59
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.59
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-6635000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
30203000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4681000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5445000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12955000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12468000
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1501000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1324000
CY2022Q2 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
794000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
935000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2277000
CY2022Q2 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
34920000
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8528000
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6493000
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
874000
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1539000
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-49000
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-30000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9179000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11266000
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-19982000
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11113000
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2337000
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-14721000
CY2023Q2 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-1588000
CY2022Q2 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
10700000
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
568000
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
580000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13055000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18879000
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
950000
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8012000
CY2022Q2 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
691000
CY2022Q2 us-gaap Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity
ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
45513000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-950000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38192000
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
783000
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2127000
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5317000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-783000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7444000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14788000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11869000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103495000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49788000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88707000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61657000
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1213000
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1031000
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1647000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
166444000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
935000
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
783000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6635000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
159962000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
116143000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2277000
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2128000
CY2022Q2 ctrn Stock Repurchased Held In Treasury During Period Value
StockRepurchasedHeldInTreasuryDuringPeriodValue
5317000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
30203000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
141179000
CY2023Q2 us-gaap Number Of Stores
NumberOfStores
608
CY2023Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
CY2023Q2 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 1.1pt 0pt;"><i style="font-family:'Helvetica';font-style:italic;">Fiscal Year</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 1.1pt 0pt;"><span style="font-family:'Helvetica';font-size:9pt;">The following contains references to fiscal years 2023 and 2022, which represent fiscal years ending or ended on February 3, 2024 and January 28, 2023, respectively. Fiscal 2023 has a </span><span style="font-family:'Helvetica';font-size:9pt;">53</span><span style="font-family:'Helvetica';font-size:9pt;">-week accounting period, and fiscal 2022 had a </span><span style="font-family:'Helvetica';font-size:9pt;">52</span><span style="font-family:'Helvetica';font-size:9pt;">-week accounting period.</span></p>
CY2024 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P371D
CY2023 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15791000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
13861000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
2860000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
2333000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8182231
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8407284
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8182231
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8407284
CY2022Q2 ctrn Stock Repurchased Held In Treasury During Period Shares
StockRepurchasedHeldInTreasuryDuringPeriodShares
170000
CY2022Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
31.20
CY2022Q2 ctrn Stock Repurchased Held In Treasury During Period Value
StockRepurchasedHeldInTreasuryDuringPeriodValue
5317000
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000.0
CY2023Q2 ctrn Period Customers Can Return Merchandise
PeriodCustomersCanReturnMerchandise
P30D
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q2 us-gaap Lease Cost
LeaseCost
19044000
CY2022Q2 us-gaap Lease Cost
LeaseCost
16540000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
43436000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
58476000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
48020000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
37240000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
27162000
CY2023Q2 ctrn Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
120839000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
335173000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
77799000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
257374000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
20820000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
14557000
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8195000
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
52327000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M13D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0460
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0371

Files In Submission

Name View Source Status
0001558370-23-010862-index-headers.html Edgar Link pending
0001558370-23-010862-index.html Edgar Link pending
0001558370-23-010862.txt Edgar Link pending
0001558370-23-010862-xbrl.zip Edgar Link pending
ctrn-20230429.xsd Edgar Link pending
ctrn-20230429x10q.htm Edgar Link pending
ctrn-20230429xex10d1.htm Edgar Link pending
ctrn-20230429xex10d1001.jpg Edgar Link pending
ctrn-20230429xex10d2.htm Edgar Link pending
ctrn-20230429xex10d2001.jpg Edgar Link pending
ctrn-20230429xex31d1.htm Edgar Link pending
ctrn-20230429xex31d2.htm Edgar Link pending
ctrn-20230429xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctrn-20230429_lab.xml Edgar Link unprocessable
ctrn-20230429_pre.xml Edgar Link unprocessable
ctrn-20230429_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctrn-20230429x10q_htm.xml Edgar Link completed
ctrn-20230429_cal.xml Edgar Link unprocessable